Follow The Filings

ROIV position history

The shares of Roivant Sciences (ROIV) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, SHS

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q2: 2,355,000 shares, $24M, 0.13% of portfolio, New
  2. 2023 Q3: 3,853,400 shares, $45M, 0.23% of portfolio, Add +63.6%
  3. 2023 Q4: 7,336,000 shares, $82M, 0.41% of portfolio, Add +90.4%
  4. 2024 Q1: 1,797,200 shares, $19M, 0.09% of portfolio, Reduce −75.5%
  5. 2024 Q2: 673,000 shares, $7.1M, 0.03% of portfolio, Reduce −62.6%
  6. 2024 Q3: 37,000 shares, $427K, <0.01% of portfolio, Reduce −94.5%
  7. 2024 Q4: 37,000 shares, $438K, <0.01% of portfolio
  8. 2025 Q1: 37,000 shares, $373K, <0.01% of portfolio
  9. 2025 Q2: 37,000 shares, $417K, <0.01% of portfolio
  10. 2025 Q3: 74,000 shares, $1.1M, <0.01% of portfolio, Add +100.0%
  11. 2025 Q4: 37,000 shares, $803K, <0.01% of portfolio, Reduce −50.0%
  12. 2026 Q1: 9,675,000 shares, $268M, 1.5% of portfolio, Add +26048.6%
  13. 2026 Q2: 14,309,000 shares, $506M, 2.3% of portfolio, Add +47.9%
  14. 2026 Q3: 21,745,533 shares, $795M, 3.4% of portfolio, Add +52.0%
Holdings date Value % of holdings Shares Filing date All 13F holders